RXi Pharmaceuticals is developing innovating therapeutics for a better life. We are a pioneer in the development of novel, self-delivering RNAi (sd-rxRNA®) therapeutics with our primary focus on dermatology and ophthalmology. RXi’s robust pipeline, coupled with an extensive patent portfolio, provides for product and business development opportunities across a broad spectrum of therapeutic areas. We are committed to being a partner of choice for academia, small companies, and large multinationals. We welcome ideas and proposals for strategic alliances, including in- and out-licensing opportunities, to advance and further develop strategic areas of interest.